FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3110523338> ?p ?o ?g. }

• W3110523338 endingPage "84" @default.
• W3110523338 startingPage "81" @default.
• W3110523338 abstract "Hemophagocytic lymphohistiocytosis (HLH) is a rare but life-threatening condition. HLH in infants and young children is usually inherited, which is then classified as primary HLH. Secondary HLH, in contrast, is caused by many different conditions such as infections, cancer or medication and affects mostly adults. HLH is a hyperinflammatory condition, which may mimic an acute septic shock. We report on a 68-year-old patient with malignant melanoma with lymph node metastases. Due to the lymphogenic progression, treatment was switched from nivolumab to dabrafenib and trametinib. Twenty-one days after initiation of BRAF/MEK inhibitor therapy, the patient presented to our emergency department with clinical signs of infection such as fever and fatigue. Laboratory tests showed excessive inflammation levels without identifying an underlying pathogen. Two days later, the patient developed an increasing pancytopenia. After extending the diagnosis, we found very high ferritin levels, hypertriglyceridemia, hypofibrinogenemia and a soluble CD25 receptor. Based on the laboratory results, prolonged fever and splenomegaly, we were able to diagnose HLH as the underlying condition. We immediately initiated treatment with intravenous prednisone, which remarkably improved the clinical symptoms. After full recovery, we reinitiated anti-tumor treatment with vemurafenib and cobimetinib, which was tolerated without side effects. Due to the relatively nonspecific nature of the clinical signs and symptoms and the significant overlap with other diseases such as sepsis, the diagnosis of HLH is often delayed. This explains, in part, the high morbidity and mortality rate. Our case shows that early treatment with steroids is effective. However, much work remains in order to raise awareness and improve the understanding of the pathophysiology of this condition." @default.
• W3110523338 created "2020-12-07" @default.
• W3110523338 creator A5005302547 @default.
• W3110523338 creator A5008654981 @default.
• W3110523338 creator A5023062926 @default.
• W3110523338 creator A5027924143 @default.
• W3110523338 creator A5038726803 @default.
• W3110523338 creator A5046274963 @default.
• W3110523338 creator A5061201698 @default.
• W3110523338 creator A5077331259 @default.
• W3110523338 creator A5087650324 @default.
• W3110523338 date "2020-11-23" @default.
• W3110523338 modified "2023-10-04" @default.
• W3110523338 title "Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature" @default.
• W3110523338 cites W2615301036 @default.
• W3110523338 cites W2793254732 @default.
• W3110523338 cites W2800368813 @default.
• W3110523338 cites W2804176908 @default.
• W3110523338 cites W2807441801 @default.
• W3110523338 cites W2893005013 @default.
• W3110523338 cites W2669166580 @default.
• W3110523338 doi "https://doi.org/10.1097/cmr.0000000000000703" @default.
• W3110523338 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33234845" @default.
• W3110523338 hasPublicationYear "2020" @default.
• W3110523338 type Work @default.
• W3110523338 sameAs 3110523338 @default.
• W3110523338 citedByCount "8" @default.
• W3110523338 countsByYear W31105233382021 @default.
• W3110523338 countsByYear W31105233382022 @default.
• W3110523338 countsByYear W31105233382023 @default.
• W3110523338 crossrefType "journal-article" @default.
• W3110523338 hasAuthorship W3110523338A5005302547 @default.
• W3110523338 hasAuthorship W3110523338A5008654981 @default.
• W3110523338 hasAuthorship W3110523338A5023062926 @default.
• W3110523338 hasAuthorship W3110523338A5027924143 @default.
• W3110523338 hasAuthorship W3110523338A5038726803 @default.
• W3110523338 hasAuthorship W3110523338A5046274963 @default.
• W3110523338 hasAuthorship W3110523338A5061201698 @default.
• W3110523338 hasAuthorship W3110523338A5077331259 @default.
• W3110523338 hasAuthorship W3110523338A5087650324 @default.
• W3110523338 hasConcept C121608353 @default.
• W3110523338 hasConcept C126322002 @default.
• W3110523338 hasConcept C184235292 @default.
• W3110523338 hasConcept C187212893 @default.
• W3110523338 hasConcept C203014093 @default.
• W3110523338 hasConcept C2776131300 @default.
• W3110523338 hasConcept C2776694085 @default.
• W3110523338 hasConcept C2777063308 @default.
• W3110523338 hasConcept C2777628635 @default.
• W3110523338 hasConcept C2777658100 @default.
• W3110523338 hasConcept C2777701055 @default.
• W3110523338 hasConcept C2778384902 @default.
• W3110523338 hasConcept C2778472372 @default.
• W3110523338 hasConcept C2778830669 @default.
• W3110523338 hasConcept C2779079688 @default.
• W3110523338 hasConcept C2779134260 @default.
• W3110523338 hasConcept C2780030458 @default.
• W3110523338 hasConcept C2994587330 @default.
• W3110523338 hasConcept C502942594 @default.
• W3110523338 hasConcept C57074206 @default.
• W3110523338 hasConcept C71924100 @default.
• W3110523338 hasConcept C86803240 @default.
• W3110523338 hasConcept C90924648 @default.
• W3110523338 hasConcept C95444343 @default.
• W3110523338 hasConceptScore W3110523338C121608353 @default.
• W3110523338 hasConceptScore W3110523338C126322002 @default.
• W3110523338 hasConceptScore W3110523338C184235292 @default.
• W3110523338 hasConceptScore W3110523338C187212893 @default.
• W3110523338 hasConceptScore W3110523338C203014093 @default.
• W3110523338 hasConceptScore W3110523338C2776131300 @default.
• W3110523338 hasConceptScore W3110523338C2776694085 @default.
• W3110523338 hasConceptScore W3110523338C2777063308 @default.
• W3110523338 hasConceptScore W3110523338C2777628635 @default.
• W3110523338 hasConceptScore W3110523338C2777658100 @default.
• W3110523338 hasConceptScore W3110523338C2777701055 @default.
• W3110523338 hasConceptScore W3110523338C2778384902 @default.
• W3110523338 hasConceptScore W3110523338C2778472372 @default.
• W3110523338 hasConceptScore W3110523338C2778830669 @default.
• W3110523338 hasConceptScore W3110523338C2779079688 @default.
• W3110523338 hasConceptScore W3110523338C2779134260 @default.
• W3110523338 hasConceptScore W3110523338C2780030458 @default.
• W3110523338 hasConceptScore W3110523338C2994587330 @default.
• W3110523338 hasConceptScore W3110523338C502942594 @default.
• W3110523338 hasConceptScore W3110523338C57074206 @default.
• W3110523338 hasConceptScore W3110523338C71924100 @default.
• W3110523338 hasConceptScore W3110523338C86803240 @default.
• W3110523338 hasConceptScore W3110523338C90924648 @default.
• W3110523338 hasConceptScore W3110523338C95444343 @default.
• W3110523338 hasIssue "1" @default.
• W3110523338 hasLocation W31105233381 @default.
• W3110523338 hasLocation W31105233382 @default.
• W3110523338 hasOpenAccess W3110523338 @default.
• W3110523338 hasPrimaryLocation W31105233381 @default.
• W3110523338 hasRelatedWork W125335819 @default.
• W3110523338 hasRelatedWork W1782200695 @default.
• W3110523338 hasRelatedWork W1982776503 @default.
• W3110523338 hasRelatedWork W1996765884 @default.
• W3110523338 hasRelatedWork W2023835753 @default.

• next